Protease-activated receptor 2

Protease-activated receptor 2 (PAR2) is a member of the protease-activated receptor family, which are a subset of G protein-coupled receptors (GPCRs). These receptors are unique in that they are activated by the cleavage of part of their extracellular domain by specific proteases.
Structure[edit]
PAR2 is a transmembrane protein that spans the cell membrane seven times, characteristic of GPCRs. The receptor is activated when a protease cleaves its extracellular N-terminus, revealing a new N-terminus that acts as a tethered ligand, binding intramolecularly to the receptor to initiate signal transduction.
Activation and Signaling[edit]
PAR2 can be activated by various proteases, including trypsin, tryptase, and certain coagulation factors. Upon activation, PAR2 couples with G proteins, leading to the activation of multiple intracellular signaling pathways, including the phospholipase C pathway, which results in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), and the activation of protein kinase C (PKC).
Physiological Roles[edit]
PAR2 is expressed in various tissues, including the gastrointestinal tract, skin, lungs, and immune system. It plays a role in numerous physiological processes such as inflammation, pain perception, wound healing, and immune response.
Inflammation[edit]
PAR2 is involved in the regulation of inflammatory responses. Activation of PAR2 on immune cells can lead to the release of pro-inflammatory cytokines and chemokines, contributing to the inflammatory process.
Pain Perception[edit]
PAR2 activation has been linked to the modulation of pain. It can sensitize nociceptors, the sensory neurons responsible for pain detection, thereby enhancing pain perception.
Wound Healing[edit]
PAR2 plays a role in the wound healing process by promoting the migration and proliferation of keratinocytes and fibroblasts, which are essential for tissue repair.
Clinical Significance[edit]
Dysregulation of PAR2 signaling has been implicated in various pathological conditions, including chronic inflammatory diseases, cancer, and allergic reactions. As a result, PAR2 is considered a potential therapeutic target for the treatment of these conditions.
See Also[edit]
References[edit]
External Links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian